Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases

Medical Oncology

Volumn 25, Issue 3, 2008, Pages 346-349

  Tas, Faruk ^a   Duranyildiz, Derya ^a   Oguz, Hilal ^a   Camlica, Hakan ^a   Yasasever, Vildan ^a   Topuz, Erkan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

bFGF; Bone metastasis; Serum; VEGF; Zoledronic acid

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN; ZOLEDRONIC ACID; ANGIOGENESIS INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; FIBROBLAST GROWTH FACTOR 2; IMIDAZOLE DERIVATIVE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG CANCER; MALE; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; BONE TUMOR; BREAST TUMOR; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMIDAZOLES; LUNG NEOPLASMS; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149241362     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9043-5     Document Type: Article

References (10)

1. JR. Green 2003 Antitumor effects of bisphosphonates Cancer 97 840 7
2. JR Green P. Clezardin 2002 Mechanisms of bisphosphonate effects on osteoclast, tumor cell growth, and metastasis Am J Clin Oncol. 25 3 9
3. P Croucher S Jagdev R. Coleman 2003 The anti-tumor potential of zoledronic acid Breast Supp. 2 S30 6
4. J Wood 2002 Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther. 302 1055 61
5. P Fournier 2002 Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats Cancer Res. 62 6538 44
6. D Santini 2002 Pamidronate induces modifications of circulating angiogenic factors in cancer patients Clin Cancer Res. 8 1080 4
7. D Santini 2003 Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients Clin Cancer Res. 9 2893 7
8. D Santini 2006 Changes in bone resorption and vascular endothelial growth factor (VEGF) after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumors Oncol Rep. 15 1351 7
9. B Vincenzi 2005 Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients J Interferon Cytokine Res. 25 144 51
10. G Ferretti 2005 Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients Oncology 69 35 43